Advanced search
Publication Cover
Modern Rheumatology Volume 28, 2018 - Issue 3
Journal homepage
320
Views
3
CrossRef citations to date
0
Altmetric
Case report

Cryoglobulinemic vasculitis with primary Sjögren’s syndrome: A case report

Jumpei HasegawaNephrology Center and Department of Rheumatology, Toranomon Hospital, Tokyo, Japan, ;Department of Nephrology, Ohkubo Hospital, Tokyo, Japan,
,
Noriko HayamiNephrology Center and Department of Rheumatology, Toranomon Hospital, Tokyo, Japan,
,
Junichi HoshinoNephrology Center and Department of Rheumatology, Toranomon Hospital, Tokyo, Japan,
,
Tatsuya SuwabeNephrology Center and Department of Rheumatology, Toranomon Hospital, Tokyo, Japan,
,
Keiichi SumidaNephrology Center and Department of Rheumatology, Toranomon Hospital, Tokyo, Japan,
,
Koki MiseNephrology Center and Department of Rheumatology, Toranomon Hospital, Tokyo, Japan,
,
Toshiharu UenoNephrology Center and Department of Rheumatology, Toranomon Hospital, Tokyo, Japan,
,
Masayuki YamanouchiNephrology Center and Department of Rheumatology, Toranomon Hospital, Tokyo, Japan,
,
Naoki SawaNephrology Center and Department of Rheumatology, Toranomon Hospital, Tokyo, Japan,
,
Kenichi OhashiDepartment of Pathology, Toranomon Hospital, Tokyo, Japan, and
,
Takeshi FujiiDepartment of Pathology, Toranomon Hospital, Tokyo, Japan, and
,
Kenmei TakaichiNephrology Center and Department of Rheumatology, Toranomon Hospital, Tokyo, Japan, ;Okinaka Memorial Institute for Medical Research, Tokyo, Japan
&
Yoshifumi UbaraNephrology Center and Department of Rheumatology, Toranomon Hospital, Tokyo, Japan, ;Okinaka Memorial Institute for Medical Research, Tokyo, JapanCorrespondence[email protected]
 show all
Pages 570-574 | Received 10 Sep 2015, Accepted 19 Nov 2015, Published online: 08 Jan 2016

References

  • Brouet JC, Clauvel JP, Danon F, Klein M, Seligmann M. Biologic and clinical significance of cryoglobulins: a report of 86 cases. Am J Med. 1974;57:775–88.
  • Ramos-Casals M, Trejo O, García-Carrasco M, Cervera R, Font J. Mixed cryoglobulinemia: new concepts. Lupus. 2000;9:83–91.
  • Sansonno D, De Re V, Lauletta G, Tucci FA, Boiocchi M, Dammacco F. Monoclonal antibody treatment of mixed cryoglobulinemia resistant to interferon alpha with an anti-CD20. Blood. 2003;101:3818–26.
  • De Vita S, Quartuccio L, Isola M, Mazzaro C, Scaini P, Lenzi M, et al. A randomized, controlled trial of rituximab for treatment of severe cryoglobulinemic vasculitis. Arthritis Rheum. 2012;64:843–53.
  • Hiramatsu R, Hoshino J, Suwabe T, Sumida K, Hasegawa E, Yamanouchi M, et al. Membranoproliferative glomerulonephritis and circulating cryoglobulins. Clin Exp Nephrol. 2014;18(1):88–94.
  • Luqmani RA, Bacon PA, Moots RJ, Janssen BA, Pall A, Emery P, et al. Birmingham Vasculitis Activity Score (BVAS) in systemic necrotizing vasculitis. QJM. 1994;87(11):671–8.
  • Meltzer M, Franklin EC. Cryoglobulinemia: a study of twenty-nine patients. I: IgG and IgM cryoglobulins and factors effecting cryoprecipitability. Am J Med. 1966;40:828–36.
  • Cacoub P, Poynard T, Ghillani P, Charlotte F, Olivi M, Piette JC, Opolon P. Extrahepatic manifestations of chronic hepatitis C. MULTIVIRC Group. Multidepartment Virus C. Arthritis Rheum. 1999;42(10):2204–12.
  • Trejo O, Ramos-Casals M, García-Carrasco M, Yagüe J, Jiménez S, de la Red G, et al. Cryoglobulinemia: study of etiologic factors and clinical and immunologic features in 443 patients from a single center. Medicine (Baltimore). 2001;80(4):252–62.
  • Saadoun D, Sellam J, Ghillani-Dalbin P, Crecel R, Piette JC, Cacoub P. Increased risks of lymphoma and death among patients with non-hepatitis C virus-related mixed cryoglobulinemia. Arch Intern Med. 2006;166(19):2101–8.
  • Ramos-Casals M, Stone JH, Cid MC, Bosch X. The cryoglobulinaemias. Lancet. 2012;379(9813):348–60.
  • Baldini C, Pepe P, Quartuccio L, Priori R, Bartoloni E, Alunno A, et al. Primary Sjogren’s syndrome as a multi-organ disease: impact of the serological profile on the clinical presentation of the disease in a large cohort of Italian patients. Rheumatology (Oxford). 2014;53:839–44.
  • Pertovaara M, Pukkala E, Laippala P, Miettinen A, Pasternack A. A longitudinal cohort study of Finnish patients with primary Sjögren’s syndrome: clinical, immunological, and epidemiological aspects. Ann Rheum Dis. 2001;60:467–72.
  • García-Carrasco M, Ramos-Casals M, Rosas J, Pallarés L, Calvo-Alen J, Cervera R, et al. Primary Sjögren syndrome: clinical and immunologic disease patterns in a cohort of 400 patients. Medicine (Baltimore). 2002;81:270–80.
  • Alamanos Y, Tsifetaki N, Voulgari PV, Venetsanopoulou AI, Siozos C, Drosos AA. Epidemiology of primary Sjögren’s syndrome in north-west Greece, 1982–2003. Rheumatology (Oxford). 2006;45:187–91.
  • Ramos-Casals M, Brito-Zerón P, Perez-De-Lis M, Jimenez I, Blanco MJ, Bove A, et al. Sjögren syndrome or Sjögren disease? The histological and immunological bias caused by the 2002 criteria. Clin Rev Allergy Immunol. 2010;38:178–85.
  • Martel C, Gondran G, Launay D, Lalloué F, Palat S, Lambert M, et al. Active immunological profile is associated with systemic Sjögren’s syndrome. J Clin Immunol. 2011;31:840–7.
  • Brito-Zerón P, Ramos-Casals M, Bove A, Sentis J, Font J. Predicting adverse outcomes in primary Sjögren’s syndrome: identification of prognostic factors. Rheumatology (Oxford). 2007;46:1359–62.
  • Brito-Zerón P, Kostov B, Solans R, Fraile G, Suárez-Cuervo C, Casanovas A, et al. Systemic activity and mortality in primary Sjögren syndrome: predicting survival using the EULAR-SS Disease Activity Index (ESSDAI) in 1045 patients. Ann Rheum Dis. 2014. [Epub ahead of print]. doi:10.1136/annrheumdis-2014-206418.
  • Cacoub P, Delluc A, Saadoun D, Landau DA, Sene D. Anti-CD20 monoclonal antibody (rituximab) treatment for cryoglobulinemic vasculitis: where do we stand? Ann Rheum Dis. 2008;67:283–7.
  • Terrier B, Krastinova E, Marie I, Launay D, Lacraz A, Belenotti P, et al. Management of noninfectious mixed cryoglobulinemia vasculitis: data from 242 cases included in the CryoVas survey. Blood. 2012;119(25):5996–6004.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.